Nektar Therapeutics

$18.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.72 (+4.06%) As of 4:05 PM UTC today

Why Robinhood?

You can buy or sell NKTR and other stocks, options, and ETFs commission-free!

About NKTR

Nektar Therapeutics Common Stock, also called Nektar Therapeutics, is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA. The listed name for NKTR is Nektar Therapeutics Common Stock.

CEO

Howard W. Robin

Employees

723

Headquarters

San Francisco, California

Founded

1990

Market Cap

3.38B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.23M

High Today

$18.75

Low Today

$17.83

Open Price

$17.85

Volume

439.49K

52 Week High

$25.06

52 Week Low

$13.63

Collections

Analyst Ratings

57%

of 14 ratings

Buy

57%

Hold

43%

Sell

NKTR Earnings

-$0.80

-$0.53

-$0.27

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, After Hours